LYONS GARY A sold 11.1% of their position (15K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $2.29M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001123343-25-000006
-15K
Net shares
Net seller
$2.29M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$47.89
Trade value
$718.35K
% of position
12.4%
12/3/2025
120.48K→135.48K
Common Stock
Direct
Shares
−15K
Price / share
$152.61
Trade value
$2.29M
% of position
11.1%
12/3/2025
135.48K→120.48K
Total
Net shares
+0.00
Net value
-$1.57M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2025 | M · Option Exercise | +15K | $47.89 | $718.35K | 12.4% | 120.48K | 135.48K |
| Common Stock Direct | 12/3/2025 | S · Sale | −15K | $152.61 | $2.29M | 11.1% | 135.48K | 120.48K |
| Total | +0.00 | -$1.57M | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
47.89
Held after
0.00
Exercisable
—
12/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock15K shares | 12/3/2025 | M · Option Exercise | −15K | 47.89 | — | 0.00 |